Japan in deal to purchase AstraZeneca’s COVID-19 vaccine

Japan is bracing for a looming second wave of coronavirus infections. (AP)

• Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer and BioNTech

TOKYO: Japan has agreed to acquire 120 million doses of AstraZeneca’s experimental COVID-19 vaccine if it is successfully developed, the health minister said on Friday.
The agreement comes after Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer Inc. and BioNTech.